EarningsQ3 2021 Earnings Report

Recursion Pharmaceuticals (RXRX) Q3 2021 Earnings Report

7 Followers

MX:RXRX Q3 2021 EPS Results

Actual EPS-$5.06

Consensus EPS-$5.06

Beat/MissMet expectations

One Year Ago EPS-$2.57

Actual Revenue$45.80M

Expected Revenue$48.35M

Beat/MissMissed by -$2.55M

YoY Revenue Growth―

QuarterQ3 2021

Date11/10/2021

TimeBefore Open

Conference CallWednesday, November 10, 2021

MX:RXRX Upcoming Earnings

Recursion Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-3.98 / -	-6.506	―
Aug 05, 2026	2026 (Q2)	-4.34 / -4.52	-7.41	39.02% (+2.89)
May 06, 2026	2026 (Q1)	-4.79 / -3.98	-9.037	56.00% (+5.06)
Feb 25, 2026	2025 (Q4)	-5.44 / -3.80	-9.579	60.38% (+5.78)
Nov 05, 2025	2025 (Q3)	-6.81 / -6.51	-6.145	-5.88% (-0.36)
Aug 05, 2025	2025 (Q2)	-6.38 / -7.41	-7.229	-2.50% (-0.18)
May 05, 2025	2025 (Q1)	-9.33 / -9.04	-7.049	-28.21% (-1.99)
Feb 28, 2025	2024 (Q4)	-7.43 / -9.58	-7.591	-26.19% (-1.99)
Nov 06, 2024	2024 (Q3)	-6.02 / -6.14	-7.772	20.93% (+1.63)
Aug 08, 2024	2024 (Q2)	-6.94 / -7.23	-6.868	-5.26% (-0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed